Company holds a total of 2,691,453 own shares.
On March 7, 2019 a total of 140,844 shares held by the company have been conveyed without consideration to 78 key employees participating in the performance period 2018 in accordance with the terms and conditions of the plan.
The decision on the directed share issue is based on the authorisation granted to the Board of Directors by the Annual General Meeting of Shareholders held on March 21, 2018.
After the share delivery, the company holds a total of 2,691,453 own shares.
Share repurchase authorization
The Annual General Meeting 2018 authorized the Board of Directors to decide upon repurchase of a maximum of 4,950,000 Company’s own shares.
Shares will be repurchased by using unrestricted equity either through a tender offer with equal terms to all shareholders at a price determined by the Board of Directors or otherwise than in proportion to the existing shareholdings of the Company’s shareholders in public trading on the Nasdaq Helsinki Ltd (the “Helsinki Stock Exchange”) at the market price quoted at the time of the repurchase.
The price paid for the shares repurchased through a tender offer under the authorization shall be based on the market price of the company’s shares in public trading. The minimum price to be paid would be the lowest market price of the share quoted in public trading during the authorization period and the maximum price the highest market price quoted during the authorization period.
Shares shall be acquired and paid for in accordance with the Rules of the Helsinki Stock Exchange and Euroclear Finland Ltd.
Shares may be repurchased to be used in implementing or financing mergers and acquisitions, developing the Company’s capital structure, improving the liquidity of the Company’s shares or to be used for the payment of the annual fee payable to the members of the Board of Directors or implementing the Company’s share-based incentive plans. In order to realize the aforementioned purposes, the shares acquired may be retained, transferred further or cancelled by the Company.
The Board of Directors will decide upon other terms related to share repurchase.
The share repurchase authorization is valid until the end of the next Annual General Meeting.
Share issue authorization
The Annual General Meeting authorized the Board of Directors to decide to issue a maximum of 15,600,000 new shares and/or transfer a maximum of 7,800,000 Company’s own shares held by the Company.
The new shares may be issued and the Company’s own shares held by the Company may be transferred either for consideration or without consideration.
The new shares may be issued and the Company’s own shares held by the Company may be transferred to the Company’s shareholders in proportion to their current shareholdings in the Company, or by disapplying the shareholders’ pre-emption right, through a directed share issue, if the Company has a weighty financial reason to do so, such as financing or implementing mergers and acquisitions, developing the capital structure of the Company, improving the liquidity of the Company’s shares or if this is justified for the payment of the annual fee payable to the members of the Board of Directors or implementing the Company’s share-based incentive plans. The directed share issue may be carried out without consideration only in connection with the implementation of the Company’s share-based incentive plan.
The subscription price of new shares shall be recorded to the invested unrestricted equity reserves. The consideration payable for Company’s own shares shall be recorded to the invested unrestricted equity reserves.
The Board of Directors will decide upon other terms related to the share issues.
The share issue authorization is valid until May 31, 2019.